Cargando…
FGFR2 testing in cholangiocarcinoma: translating molecular studies into clinical practice
Cholangiocarcinoma (CCA) is a heterogeneous group of neoplasms burdened by a dismal prognosis. Several studies have investigated the genomic profile of CCA and identified numerous druggable genetic alterations, including FGFR2 fusions/rearrangements. Approximately 5-7% of CCAs and 10-20% of intrahep...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Pacini Editore srl
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462997/ https://www.ncbi.nlm.nih.gov/pubmed/37017301 http://dx.doi.org/10.32074/1591-951X-859 |